Form 4: Altair Engineering Director Teresa Harris Reports Stock Option Exercise and Sale

Sentiment:

SEC Form 4 Filing


Director Teresa Harris of Altair Engineering Inc. reports exercising stock options and selling shares under a pre-arranged 10b5-1 plan.

Summary

  • On July 9, 2024, Teresa A Harris, a director of Altair Engineering Inc., executed transactions involving the company's Class A Common Stock.
  • Harris exercised stock options to acquire 620 shares at a price of $4.52 per share.
  • Simultaneously, Harris sold 620 shares of Class A Common Stock at a price of $97.73 per share.
  • These transactions were conducted under a pre-existing 10b5-1 trading plan established on November 15, 2023.
  • Following these transactions, Harris directly owns 21,242 shares of Class A Common Stock, including 2,347 unvested restricted stock units, and holds options for 14,500 shares.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing insider trading activity, which is neither particularly positive nor negative. The transactions are part of a pre-arranged plan, suggesting no immediate cause for concern.

Industry Context

This filing is a routine disclosure of insider transactions. It is common for executives and directors to have pre-arranged trading plans (Rule 10b5-1) to avoid accusations of trading on inside information.

Comparison to Industry Standards

  • Insider trading activity is a common occurrence in publicly traded companies.
  • The use of 10b5-1 trading plans is a standard practice to ensure compliance with insider trading regulations.
  • The reported transactions are typical for directors who receive stock options as part of their compensation.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders due to the change in ownership, but the pre-arranged nature of the trades mitigates concerns about insider information being used.

Key Dates

DateDescription
11/15/2023Date of establishment of the Rule 10b5-1 trading plan
11/23/2017Commencement date of vesting for the stock options, vesting in two equal annual installments
07/09/2024Date of stock option exercise and sale of shares
07/10/2024Date of signature on the Form 4 filing
11/23/2026Expiration date of the stock options

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.